📰 Rom News
Page 576 - Rom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.
May 11, 2023
Falko Friedrichs from Deutsche Bank retains his positive opinion on the stock with a Buy rating. The target price is unchanged and still at EUR 64. | May 11, 2023
May 11, 2023
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDASAN FRANCISCO, CA / ACCESSWIRE / May 11, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or
May 11, 2023
PetroTal Corp - Calgary, Canada-based, Peru-focused oil and gas company - Says production in the first three months of the year was 12,618 barrels of oil per day, up 22% from 10,374 bopd the previous... | May 11, 2023
May 11, 2023
Equita Group Spa reported Thursday that it saw its revenues grow to EUR19.3 million in the first quarter of 2023, up 5.0 percent from EUR18.4 million in the first quarter of 2022. Profit amounted to... | May 11, 2023
May 11, 2023
TXT e-solutions Spa reported that its board of directors on Thursday met to approve operating results as of March 31, reporting a net profit of EUR2.9 million, up 40 percent from EUR2.1 million in the... | May 11, 2023
May 11, 2023
According to a study published in the ERJ Open Research, around one in five people might be suffering from obstructive sleep apnoea (OSA).
May 11, 2023
BOTHELL, WA / ACCESSWIRE / May 11, 2023 / VaporBrands International, Inc. dba E-Cite Motors Group, (OTC PINK:VAPR) announced that it has received approval from the The California Air Resources Board (CARB)
May 11, 2023
AECOM , the world’s trusted infrastructure consulting firm, announced today that its joint venture was awarded a contract from the U.S. Army Corps of Engineers to deliver per-and... | May 11, 2023
May 11, 2023
Analyst Molly Wylenzek from Jefferies research considers the stock attractive and recommends it with a Buy rating. The target price is reviewed upwards from EUR 128 to EUR 144. | May 11, 2023
May 11, 2023
Updated iptacopan data confirm hemolysis control in paroxysmal nocturnal hemoglobinuria patients from Phase III APPLY-PNH and APPOINT-PNH studies Head-to-head data from Phase III... | May 11, 2023